Paraoxonase Inhibition by Propranolol

Authors

Alireza Jahangiri1, Masoud Mahmoudian2, Hassan Jalalizadeh1, Abbas Shafiee1,*
1Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2Department of Pharmacology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Email:[email protected]

IJ Pharmaceutical Research:Vol. 3, issue 3; 155-158
Published online:Nov 20, 2010
Article type:Research Article
Received:Dec 01, 2003
Accepted:May 01, 2004
How to Cite:Jahangiri A, Mahmoudian M, Jalalizadeh H, Shafiee A. Paraoxonase Inhibition by Propranolol. Iran J Pharm Res. 2022;3(3):e128199. doi: https://doi.org/10.22037/ijpr.2010.593

Abstract

There are many evidences that human serum paraoxonase activity modifies plasma lipid profile and paraoxonase has an antiatherogenic property. Non-selective beta-blockers affect plasma lipid profile too, but they have atherogenic property when patients take these drugs in long term. In this study the effect of propranolol, a non-selective beta-blocker, on paraoxonase activity was investigated. Lineweaver-Burk and secondary plots were drawn and showed that propranolol is a mixed non-competitive inhibitor of paraoxonase.

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Oct
2008

Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease

Abdolkarim Mahrooz,
Mohammad Nori,
MohammadReza Rashidi,
Naser AslanAbadi,
Dardi Ghojegh,
Atefeh Azari

Mahrooz A, Nori M, Rashidi M, AslanAbadi N, Ghojegh D, et al. Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease. koomesh. 2008;10(1):e152212. doi:

25
Mar
2011

Determination of serum paraoxonase phenotype distribution by double-substrate method in patients with coronary artery disease

Abdolkarim Mahrooz,
Mohammad Nori,
Mohammad-Reza Rashidi,
Naser AslanAbadi,
Durdi Ghojagh

Mahrooz A, Nori M, Rashidi M, AslanAbadi N, Ghojagh D. Determination of serum paraoxonase phenotype distribution by double-substrate method in patients with coronary artery disease. koomesh. 2011;12(3):e152455. doi:

31
Jan
2014

Synthesis of Brominated 2-Phenitidine Derivatives as Valuable Inhibitors of Cholinesterases for the Treatment of Alzheimer’s Disease

Muhammad Athar Abbasi,
Amna Saeed,
Aziz-ur-Rehman,
Khalid Mohmmed Khan,
Muhammad Ashraf,
Syeda Abida Ejaz

Abbasi MA, Saeed A, Aziz-ur-Rehman , Mohmmed Khan K, Ashraf M, et al. Synthesis of Brominated 2-Phenitidine Derivatives as Valuable Inhibitors of Cholinesterases for the Treatment of Alzheimer’s Disease. Iran J Pharm Res. 2014;13(1):e125445. doi: https://doi.org/10.22037/ijpr.2014.1450

31
Oct
2011

Enhancement of Frequency Domain Indices of Heart Rate Variability by Cholinergic Stimulation with Pyridostigmine Bromide

Ali Asghar Zarei,
Seyyed Abbas Foroutan,
Seyyed Mohsen Foroutan,
Abbas Erfanian Omidvar

Zarei AA, Foroutan SA, Foroutan SM, Erfanian Omidvar A. Enhancement of Frequency Domain Indices of Heart Rate Variability by Cholinergic Stimulation with Pyridostigmine Bromide. Iran J Pharm Res. 2011;10(4):e125994. doi: https://doi.org/10.22037/ijpr.2011.987

3
Feb
2024
In vitro Effects of Propofol and Bupivacaine on Pregnant Women’s Plasma Cholinesterase Activity and Malondialdehyde Level

In vitro Effects of Propofol and Bupivacaine on Pregnant Women’s Plasma Cholinesterase Activity and Malondialdehyde Level

Rozheen Shukri Karam,
Fouad Kasim Mohammad

Karam RS, Mohammad FK. In vitro Effects of Propofol and Bupivacaine on Pregnant Women’s Plasma Cholinesterase Activity and Malondialdehyde Level. J Cell Mol Anesth. 2024;9(1):e145364. doi: https://doi.org/10.5812/jcma-145364

More by these authors

Alireza JahangiriPubMedScholar
Masoud MahmoudianPubMedScholar
Hassan JalalizadehPubMedScholar
Abbas ShafieePubMedScholar
Share
Cited by
Metrics